Akoya Biosciences, Inc. (AKYA) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2025-07-08

Akoya Biosciences, Inc. (AKYA) — no SEC Form 4 insider filings recorded in the last 90 days. InsiderAlpha tracks every AKYA SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About Akoya Biosciences, Inc. (AKYA)

SEC CIK0001711933

Recent AKYA Insider Transactions (Form 4)

DateInsiderRoleTransactionSharesPriceValueFiling
LAI GOLDMAN MYLADirectorJ — Other acquisition / disposition20.0KSEC
Raffin Thomas A.DirectorJ — Other acquisition / disposition234.6KSEC
Raffin Thomas A.DirectorJ — Other acquisition / disposition1.74MSEC
Raffin Thomas A.DirectorJ — Other acquisition / disposition15.94MSEC
Mendel ScottDirectorJ — Other acquisition / disposition28.5KSEC
Winkler MatthewDirectorJ — Other acquisition / disposition984.5KSEC
McKelligon BrianPresident and CEOJ — Other acquisition / disposition393.3KSEC
McKelligon BrianPresident and CEOJ — Other acquisition / disposition331.1KSEC
McKelligon BrianPresident and CEOF — Tax withholding / forfeiture196.9KSEC
McKelligon BrianPresident and CEOJ — Other acquisition / disposition947.7KSEC
Kamocsay JenniferChief Legal OfficerJ — Other acquisition / disposition16.8KSEC
Kamocsay JenniferChief Legal OfficerJ — Other acquisition / disposition162.5KSEC
Ramachandran Niro Ph.DChief Business OfficerJ — Other acquisition / disposition62.6KSEC
Ramachandran Niro Ph.DChief Business OfficerF — Tax withholding / forfeiture42.1KSEC
Ramachandran Niro Ph.DChief Business OfficerJ — Other acquisition / disposition151.9KSEC

All transactions sourced from SEC EDGAR Form 4 filings for Akoya Biosciences, Inc. (AKYA). Updated in real time as new filings are submitted to the SEC.

Recent Insider Filings

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in AKYA insider filings:

POpen-market purchase by the insider
SOpen-market sale by the insider
AGrant, award, or other acquisition from the issuer
MExercise or conversion of derivative security (e.g. options)
FPayment of exercise price or tax liability via share withholding
GBona-fide gift of securities
DDisposition to the issuer (e.g. share buyback participation)
JOther acquisition or disposition
XExercise of in-the-money or at-the-money derivative security
CConversion of derivative security
VTransaction voluntarily reported earlier than required

AKYA Insider Trading — FAQ

What is the latest insider trade for AKYA?
Akoya Biosciences, Inc. (AKYA) had 0 insider filings in the last 90 days, with the most recent on 2025-07-08. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying AKYA stock?
0 insider purchases of AKYA were filed in the last 90 days.
How many insiders are selling AKYA stock?
0 insider sales of AKYA were filed in the last 90 days.
Where can I see AKYA SEC filings (Form 4, 10-K, 10-Q, 8-K)?
InsiderAlpha aggregates every AKYA SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Learn More

Open the live AKYA dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.